HIV prevention study seeks to find which injectable works best for patients

NCT ID NCT07379658

First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 15 times

Summary

This study looks at how satisfied people are with two different long-acting injectable HIV prevention medications (lenacapavir and cabotegravir). About 128 adults in Louisville, KY who are already using or starting one of these shots will fill out surveys and interviews over 12 months. The goal is to understand real-world effectiveness and what helps people stick with their prevention plan.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Norton Healthcare

    Louisville, Kentucky, 40202, United States

    Contact

  • University of Louisville, Kent School of Social Work

    Louisville, Kentucky, 40292, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Louisville, School of Public Health and Information Sciences

    Louisville, Kentucky, 40202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.